These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8652244

  • 1. Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).
    Andreyev HJ, Norman AR, Cunningham D, Padhani AR, Hill AS, Ross PJ, Webb A.
    Eur J Cancer; 1995 Dec; 31A(13-14):2209-14. PubMed ID: 8652244
    [Abstract] [Full Text] [Related]

  • 2. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, Watson M, Hill AS, Nicolson MC, O'Brien ME, Evans TC, Nicolson V.
    Cancer; 1996 May 15; 77(10):1978-85. PubMed ID: 8640659
    [Abstract] [Full Text] [Related]

  • 3. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.
    Geh JI, Glynne-Jones R, Kwok QS, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC.
    Clin Oncol (R Coll Radiol); 2000 May 15; 12(3):182-7. PubMed ID: 10942336
    [Abstract] [Full Text] [Related]

  • 4. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).
    Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H.
    Ann Oncol; 1994 Sep 15; 5(7):609-16. PubMed ID: 7993836
    [Abstract] [Full Text] [Related]

  • 5. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
    Melcher AA, Mort D, Maughan TS.
    Br J Cancer; 1996 Nov 15; 74(10):1651-4. PubMed ID: 8932350
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
    Bamias A, Cunningham D, Nicolson V, Norman A, Hill M, Nicolson M, O'Brien M, Webb A, Hill A.
    Br J Cancer; 1995 Mar 15; 71(3):583-6. PubMed ID: 7880742
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
    Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A.
    J Clin Oncol; 2002 Apr 15; 20(8):1996-2004. PubMed ID: 11956258
    [Abstract] [Full Text] [Related]

  • 8. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.
    Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH.
    J Korean Med Sci; 2002 Jun 15; 17(3):348-52. PubMed ID: 12068138
    [Abstract] [Full Text] [Related]

  • 9. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.
    Ellis PA, Norman A, Hill A, O'Brien ME, Nicolson M, Hickish T, Cunningham D.
    Eur J Cancer; 1995 Sep 15; 31A(10):1594-8. PubMed ID: 7488407
    [Abstract] [Full Text] [Related]

  • 10. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP.
    Cancer; 1995 May 01; 75(9):2197-202. PubMed ID: 7712428
    [Abstract] [Full Text] [Related]

  • 11. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
    Faivre C, Rougier P, Ducreux M, Mitry E, Lusinchi A, Lasser P, Elias D, Eschwege F.
    Bull Cancer; 1999 Oct 01; 86(10):861-5. PubMed ID: 10572237
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S, Parshad R, Kapoor A, Gupta SD, Kumar A, Chattophadyay TK.
    Indian J Cancer; 2004 Oct 01; 41(1):3-7. PubMed ID: 15105572
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y, Qiu XH, Yang YX, Zhang SQ, Chen ZM.
    Ai Zheng; 2006 Aug 01; 25(8):1029-34. PubMed ID: 16965688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.
    Karapetis CS, Yip D, Virik K, Strickland A, Ryder K, Cowling M, Harper PG.
    Med Oncol; 2001 Aug 01; 18(1):23-32. PubMed ID: 11778966
    [Abstract] [Full Text] [Related]

  • 16. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
    Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F.
    Anticancer Drugs; 2009 Mar 01; 20(3):165-73. PubMed ID: 19125117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma.
    Honda M, Miura A, Izumi Y, Kato T, Ryotokuji T, Monma K, Fujiwara J, Egashira H, Nemoto T.
    Dis Esophagus; 2010 Nov 01; 23(8):641-5. PubMed ID: 20545978
    [Abstract] [Full Text] [Related]

  • 19. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.
    Int J Radiat Oncol Biol Phys; 2003 Jun 01; 56(2):328-34. PubMed ID: 12738305
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):415-20. PubMed ID: 15235823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.